Image_2_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Image_3_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Table_2_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Image_1_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Table_1_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Image_4_Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Ta... by Binbin Yang (2259313)

“…Objective<p>Systemic lupus erythematosus (SLE) is an autoimmune disease with complex etiology that is not yet entirely understood. We aimed to elucidate the mechanisms and therapeutic potential of microRNAs (miRNAs) in SLE in a Tibetan population.…”

Fig 3 - by Sirinun Boripuntakul (13994171)

Fig 1 - by Zemene Demelash Kifle (10725040)

Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

Fig 1 - by Maris Lohmöller (16985922)

Prognostic capacity of sBTLA on day 7. by Anna Lange (583057)

Alterations of egg transparency by drugs containing inhibitors of physiological functions. by Takumi T. Shito (11849291)

Participant Recruitment Flowchart. by Sandra M. Ragheb (12975445)

Characteristics of Participants (n = 65). by Sandra M. Ragheb (12975445)

Patient Engagement Panel Key Messages. by Sandra M. Ragheb (12975445)

Screenshots of the mHealth Platform. by Sandra M. Ragheb (12975445)

Hh signaling activation by dnPKA-GFP decreases p53 target <i>cyclinG1</i> expression and suppresses apoptosis in <i>shh</i>^−/− mutant embryos. by Sergey V. Prykhozhij (239274)

“…All of EGFP-injected embryos had “low” expression of <i>patched1</i>, 25,3 +/− 1,15% (Mean +/− standard deviation) of them had “high” expression of <i>cyclinG1</i> and 24,7 +/− 1,53% had “high” apoptosis levels. dnPKA-GFP mRNA injection led to “high” expression of <i>patched1</i> in 87,7 +/− 3,8% of embryos and decreased expression of <i>cyclinG1</i> and apoptosis levels: “high” proportions are 6 +/− 2% and 5,8 +/− 2,4%, respectively. …”

Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Association Between App Feasibility and Quality of Life and 30-Day Hospital Readmission. by Sandra M. Ragheb (12975445)